82 results
Page 4 of 5
8-K
EX-99.1
zks9453hp4tsmwmlqw9
18 Dec 14
Fate Therapeutics Announces Interim Data From Ongoing Phase 2 PUMA Study of PROHEMA in Adults with Hematologic Malignancies
12:00am
S-3
qcbml
1 Oct 14
Shelf registration
12:00am
S-3
EX-4.2
lqcs4a2orr5zqvfo j0z
1 Oct 14
Shelf registration
12:00am
S-3
EX-4.1
mzlgyf4e0
1 Oct 14
Shelf registration
12:00am
8-K
EX-10.2
krqe gmrf
5 Aug 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
ubpo7jcoq1 7eisjn
5 Aug 14
Entry into a Material Definitive Agreement
12:00am
10-K
u3vx8sd6eh yz55acj
17 Mar 14
Annual report
12:00am
10-Q
3fxbofna
13 Nov 13
Quarterly report
12:00am
424B4
j3extv ak04j3har
1 Oct 13
Prospectus supplement with pricing info
12:00am
DRS/A
8ctbzv44
29 Jul 13
Draft registration statement (amended)
12:00am
DRS/A
EX-4
3fllt9epi0v53r2k c0d
29 Jul 13
Draft registration statement (amended)
12:00am